What is a "good enough" termination?

Journal of the American Psychoanalytic Association
Glen O Gabbard

Abstract

In Freud's technique papers, he failed to develop a systematic approach to termination. Much of the existing literature is based on psychoanalytic mythologies about the way patients are expected to end analysis. The models described in the literature are often starkly at odds with what one sees in clinical practice. A wish for idealized versions of termination underlies much of what has been written, and we need to shift to a conceptual model involving "good enough" termination. A number of different endings to psychoanalysis may, in the long run, lead to productive outcomes; these models are examined, as are various approaches to the dilemmas presented at the time of termination.

References

Jan 1, 1976·Journal of the American Psychoanalytic Association·H F NormanW G Barrett
Oct 1, 1995·British Journal of Urology·P D McInerneyA R Mundy
Jan 1, 1995·Journal of the American Psychoanalytic Association·F Busch
Jan 1, 1993·Journal of the American Psychoanalytic Association·A Z Pfeffer
Nov 4, 2000·Journal of the American Psychoanalytic Association·G O Gabbard
Nov 4, 2000·Journal of the American Psychoanalytic Association·S Orgel
May 23, 2002·Journal of the American Psychoanalytic Association·Drew Westen, Glen O Gabbard
May 23, 2002·Journal of the American Psychoanalytic Association·Drew Westen, Glen O Gabbard
Jul 13, 2002·Chest·Emma Flynn, Ronan O'Driscoll
May 7, 2003·Journal of the American Psychoanalytic Association·Susan Loden
Jan 1, 1953·Journal of the American Psychoanalytic Association·K R EISSLER
Sep 19, 2003·The International Journal of Psycho-analysis·Glen O Gabbard, Drew Westen
Jan 10, 2004·Journal of the American Psychoanalytic Association·Nancy J Chodorow
Mar 8, 2005·Intensive Care Medicine·H Barrett, J F Bion
Dec 1, 2005·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·W R Mayr
Dec 6, 2005·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·W R Mayr
Jun 1, 2007·The International Journal of Psycho-analysis·Glen O Gabbard
Nov 7, 2007·Psychoanalytic Review·Andrea Sabbadini
Apr 23, 2009·The International Journal of Psycho-analysis·Glen O Gabbard, Thomas H Ogden

❮ Previous
Next ❯

Citations

Mar 14, 2012·Bulletin of the Menninger Clinic·Sergio V Delgado, Jeffrey R Strawn
Nov 29, 2013·Psychodynamic Psychiatry·Cathy R SchenMalkah Notman
Oct 9, 2012·The Psychoanalytic Quarterly·Alan Sugarman
Oct 10, 2012·The International Journal of Psycho-analysis·Giovanna Goretti Regazzoni
Jan 19, 2013·The Psychoanalytic Quarterly·Judy L Kantrowitz
Sep 21, 2010·Journal of the American Psychoanalytic Association·Thomas H Ogden, Glen O Gabbard
May 30, 2014·Journal of the American Psychoanalytic Association·Ellen Pinsky
Jun 12, 2010·Journal of the American Psychoanalytic Association·Nancy J Chodorow
Oct 9, 2012·Journal of the American Psychoanalytic Association·Luke Hadge
Dec 1, 2010·Journal of the American Psychoanalytic Association·Lee I Ascherman
Dec 1, 2010·Journal of the American Psychoanalytic Association·Alan Sugarman
Feb 18, 2011·The International Journal of Psycho-analysis·François Sirois
Jun 4, 2021·The International Journal of Psycho-analysis·Glen O Gabbard
Jul 3, 2021·International Journal of Environmental Research and Public Health·Arne Kristian HenriksenHanne-Sofie Johnsen Dahl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.